is being presented by Dr. David Lim, Founder, of Regulatory Doctor and airs on Tuesday, March 27th, 2012. For more details, or to register please visit our site at www.fxconferences.com
In the United States, scientific studies designed to develop evidence to support the safety and effectiveness of investigational drugs, biological products and medical devices (including in vitro diagnostic devices) are regulated by the Food and Drug Administration (FDA). Those conducting these clinical studies – such as clinical investigators, sponsors, monitors, and CROs – must comply with the applicable statutes and regulations governing good clinical practice (GCP).
This audio conference presentation is intended to provide attendees with a detailed review and understanding of the FDA regulations applicable for clinical trials or studies, and requirements for compliance. Our speaker drawns upon extensive industry experience and shares insight on the various aspects of GCP, empowering attendees with the key information they need regarding FDA regulations and requirements.
